Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale
- PMID: 24973133
- PMCID: PMC4331070
- DOI: 10.1007/s10096-014-2188-6
Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale
Abstract
The objective of this study was to investigate the observation of daptomycin resistance in Corynebacterium striatum, both in vivo and in vitro. We describe a case of C. striatum bacteremia in a patient with a left ventricular assist device (LVAD); the initial isolate recovered was daptomycin susceptible with a minimum inhibitory concentration (MIC) of 0.125 μg/ml. Two months later, and after daptomycin therapy, the individual became bacteremic with an isolate of C. striatum with a daptomycin MIC of >256 μg/ml. To study the prevalence of daptomycin resistance in C. striatum, clinical isolates of C. striatum were grown in broth culture containing daptomycin to investigate the emergence of resistance to this antimicrobial. Molecular typing was used to evaluate serial isolates from the index patient and the clinical isolates of C. striatum we assayed. In vitro analysis of isolates from the index patient and 7 of 11 additional C. striatum isolates exhibited the emergence of high-level daptomycin resistance, despite initially demonstrating low MICs to this antimicrobial agent. This phenotype was persistent even after serial subculture in the absence of daptomycin. Together, these data demonstrate that caution should be taken when using daptomycin to treat high-inoculum infections and/or infections of indwelling medical devices with C. striatum. To our knowledge, this is the first report characterizing the emergence of daptomycin resistance in C. striatum.
Conflict of interest statement
Figures

Similar articles
-
Mechanism of High-Level Daptomycin Resistance in Corynebacterium striatum.mSphere. 2018 Aug 8;3(4):e00371-18. doi: 10.1128/mSphereDirect.00371-18. mSphere. 2018. PMID: 30089649 Free PMC article.
-
Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections.Microb Drug Resist. 2016 Apr;22(3):233-7. doi: 10.1089/mdr.2015.0208. Epub 2015 Nov 6. Microb Drug Resist. 2016. PMID: 26544621 Free PMC article.
-
Bacteremia due to high-level daptomycin-resistant Corynebacterium striatum: A case report with genetic investigation.J Infect Chemother. 2019 Nov;25(11):906-908. doi: 10.1016/j.jiac.2019.04.009. Epub 2019 May 14. J Infect Chemother. 2019. PMID: 31101531
-
Clinical and microbiological characteristics of high-level daptomycin-resistant Corynebacterium species: A systematic scoping review.J Infect Chemother. 2025 Feb;31(2):102575. doi: 10.1016/j.jiac.2024.12.004. Epub 2024 Dec 3. J Infect Chemother. 2025. PMID: 39638285
-
Treat Me Well or Will Resist: Uptake of Mobile Genetic Elements Determine the Resistome of Corynebacterium striatum.Int J Mol Sci. 2021 Jul 13;22(14):7499. doi: 10.3390/ijms22147499. Int J Mol Sci. 2021. PMID: 34299116 Free PMC article. Review.
Cited by
-
Factors affecting the clinical relevance of Corynebacterium striatum isolated from blood cultures.PLoS One. 2018 Jun 21;13(6):e0199454. doi: 10.1371/journal.pone.0199454. eCollection 2018. PLoS One. 2018. PMID: 29928059 Free PMC article.
-
Infective Endocarditis Due to Corynebacterium Species: Clinical Features and Antibiotic Resistance.Open Forum Infect Dis. 2021 Feb 4;8(3):ofab055. doi: 10.1093/ofid/ofab055. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 33738317 Free PMC article.
-
Mechanisms of drug resistance: daptomycin resistance.Ann N Y Acad Sci. 2015 Sep;1354:32-53. doi: 10.1111/nyas.12948. Epub 2015 Oct 23. Ann N Y Acad Sci. 2015. PMID: 26495887 Free PMC article. Review.
-
Mechanism of High-Level Daptomycin Resistance in Corynebacterium striatum.mSphere. 2018 Aug 8;3(4):e00371-18. doi: 10.1128/mSphereDirect.00371-18. mSphere. 2018. PMID: 30089649 Free PMC article.
-
The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report.BMC Infect Dis. 2022 Mar 26;22(1):290. doi: 10.1186/s12879-022-07270-0. BMC Infect Dis. 2022. PMID: 35346085 Free PMC article.
References
-
- Corona Perez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfan E, Amat Mateu C, Flores Sanchez X. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. The Journal of antimicrobial chemotherapy. 2012;67(7):1749–1754. doi: 10.1093/jac/dks119. - DOI - PubMed
-
- Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(3):347–354. doi: 10.1093/cid/cir805. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical